Insider · CIK 0001115331
Christopher G Kennedy
Files at TILE (INTERFACE INC). First filing -, latest -.
In brief
Christopher G Kennedy files SEC Form 4 as director at TILE (INTERFACE INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Christopher G Kennedy has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 19, 2026 | TILE INTERFACE INC | AGrant or award Common Stock | +6,067 | $0.00 | $0 | 152,934 | May 20, 2026 |
| Mar 5, 2026 | TILE INTERFACE INC | JOther Common Stock | -15,500 | $28.43 | $441k | 146,867 | Mar 6, 2026 |
| May 15, 2025 | TILE INTERFACE INC | AGrant or award Common Stock | +8,294 | $0.00 | $0 | 162,367 | May 16, 2025 |
| Dec 4, 2024 | TILE INTERFACE INC | JOther Common Stock | -38,000 | $26.29 | $999k | 154,073 | Dec 5, 2024 |
Questions about Christopher G Kennedy
Answered from the filings on this page, as of the latest one.
Is Christopher G Kennedy buying or selling?
Christopher G Kennedy has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Christopher G Kennedy's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Christopher G Kennedy has 0.
Where does Christopher G Kennedy file Form 4?
Christopher G Kennedy has filed Form 4 at TILE (INTERFACE INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.